United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $773,721,457.77
- Nov. 11, 2024
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 21, 2013 | EVP | 6,000 | $92.47 | Sell | $554,820.00 | |
Nov. 21, 2013 | CEO | 3,833 | $92.49 | Sell | $354,514.17 | |
Nov. 15, 2013 | COO | 10,000 | $94.00 | Sell | $940,000.00 | |
Nov. 14, 2013 | Director | 5,500 | $91.65 | Sell | $504,075.00 | |
Nov. 14, 2013 | CEO | 3,833 | $91.60 | Sell | $351,102.80 | |
Nov. 7, 2013 | CEO | 3,833 | $89.47 | Sell | $342,938.51 | |
Nov. 7, 2013 | EVP | 6,000 | $89.60 | Sell | $537,600.00 | |
Nov. 7, 2013 | Director | 3,500 | $90.51 | Sell | $316,785.00 | |
Nov. 1, 2013 | COO | 10,000 | $90.34 | Sell | $903,400.00 | |
Nov. 1, 2013 | Director | 3,000 | $89.18 | Sell | $267,540.00 | |
Oct. 31, 2013 | CEO | 3,833 | $86.89 | Sell | $333,049.37 | |
Oct. 24, 2013 | CEO | 3,833 | $83.77 | Sell | $321,090.41 | |
Oct. 18, 2013 | COO | 10,000 | $82.47 | Sell | $824,700.00 | |
Oct. 17, 2013 | CFO | 2,750 | $82.01 | Sell | $225,527.50 | |
Oct. 17, 2013 | EVP | 6,000 | $81.79 | Sell | $490,740.00 | |
Oct. 17, 2013 | CEO | 3,833 | $81.84 | Sell | $313,692.72 | |
Oct. 10, 2013 | CEO | 3,833 | $82.58 | Sell | $316,529.14 | |
Oct. 4, 2013 | COO | 10,000 | $85.48 | Sell | $854,800.00 | |
Oct. 3, 2013 | Director | 1,500 | $83.15 | Sell | $124,725.00 | |
Oct. 3, 2013 | CFO | 4,500 | $84.67 | Sell | $381,015.00 | |
Oct. 3, 2013 | CEO | 3,833 | $84.20 | Sell | $322,738.60 | |
Oct. 3, 2013 | EVP | 6,000 | $84.38 | Sell | $506,280.00 | |
Sept. 26, 2013 | CEO | 3,833 | $78.41 | Sell | $300,545.53 | |
Sept. 20, 2013 | COO | 10,000 | $77.86 | Sell | $778,600.00 | |
Sept. 19, 2013 | EVP | 6,000 | $78.02 | Sell | $468,120.00 | |
Sept. 19, 2013 | CEO | 3,833 | $78.12 | Sell | $299,433.96 | |
Sept. 19, 2013 | CFO | 4,500 | $78.67 | Sell | $354,015.00 | |
Sept. 12, 2013 | CEO | 3,833 | $76.98 | Sell | $295,064.34 | |
Sept. 6, 2013 | COO | 10,000 | $73.67 | Sell | $736,700.00 | |
Sept. 5, 2013 | Director | 1,500 | $73.11 | Sell | $109,665.00 | |
Sept. 5, 2013 | CEO | 3,833 | $73.63 | Sell | $282,223.79 | |
Sept. 5, 2013 | EVP | 6,000 | $73.29 | Sell | $439,740.00 | |
Sept. 5, 2013 | CFO | 4,500 | $74.17 | Sell | $333,765.00 | |
Aug. 29, 2013 | CEO | 3,833 | $72.76 | Sell | $278,889.08 | |
Aug. 22, 2013 | CEO | 3,833 | $72.06 | Sell | $276,205.98 | |
Aug. 16, 2013 | COO | 10,000 | $71.21 | Sell | $712,100.00 | |
Aug. 15, 2013 | EVP | 6,000 | $71.34 | Sell | $428,040.00 | |
Aug. 15, 2013 | CEO | 3,833 | $71.58 | Sell | $274,366.14 | |
Aug. 15, 2013 | CFO | 4,500 | $71.14 | Sell | $320,130.00 | |
Aug. 8, 2013 | CEO | 3,833 | $73.11 | Sell | $280,230.63 | |
Aug. 2, 2013 | COO | 10,000 | $76.69 | Sell | $766,900.00 | |
Aug. 1, 2013 | CFO | 4,500 | $75.87 | Sell | $341,415.00 | |
Aug. 1, 2013 | Director | 3,000 | $75.94 | Sell | $227,820.00 | |
Aug. 1, 2013 | CEO | 3,833 | $75.97 | Sell | $291,193.01 | |
Aug. 1, 2013 | EVP | 6,000 | $75.91 | Sell | $455,460.00 | |
July 31, 2013 | Director | 7,500 | $74.93 | Sell | $561,975.00 | |
July 25, 2013 | CEO | 3,833 | $71.45 | Sell | $273,867.85 | |
July 19, 2013 | COO | 10,000 | $70.00 | Sell | $700,000.00 | |
July 18, 2013 | CEO | 3,833 | $68.96 | Sell | $264,323.68 | |
July 18, 2013 | EVP | 6,000 | $69.15 | Sell | $414,900.00 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, James Edgemond, Nilda Mesa, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Michael Benkowitz, Ray Kurzweil, Paul A. Mahon, Louis Sullivan, R Paul Gray, Judy D. Olian, Tommy G. Thompson, DWEK RAYMOND, and MAHON PAUL A
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on Nov. 11, 2024.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Michael Benkowitz with a total value of $8,084,500.00 on Aug. 7, 2024.